Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

The Effects of Duodenojejunal Omega Switch in Combination with High-Fat Diet and Control Diet on Incretins, Body Weight, and Glucose Tolerance in Sprague-Dawley Rats.

Stygar D, Sawczyn T, Skrzep-Poloczek B, Owczarek AJ, Matysiak N, Michalski M, Mielańczyk Ł, Bażanów B, Ziora P, Choręza P, Doleżych B, Karcz KW.

Obes Surg. 2018 Mar;28(3):748-759. doi: 10.1007/s11695-017-2883-3.

2.

Decreased Cardiovascular Risk after Roux-en-Y Gastric Bypass Surgery in Chinese Diabetic Patients with Obesity.

Zhao X, Duan W, Sun C, Li Z, Liu Y, Xiao X, Wang G, Gang X, Wang G.

J Diabetes Res. 2017;2017:5612049. doi: 10.1155/2017/5612049. Epub 2017 Jul 4.

3.

Diabetes recurrence after metabolic surgeries correlates with re-impaired insulin sensitivity rather than beta-cell function.

Liu T, Zhong MW, Liu Y, Sun D, Wei M, Huang X, Cheng YG, Wu QZ, Wu D, Zhang XQ, Wang KX, Hu SY, Liu SZ.

World J Gastroenterol. 2017 May 21;23(19):3468-3479. doi: 10.3748/wjg.v23.i19.3468.

4.

Diabetes after Bariatric Surgery.

Shah A, Laferrère B.

Can J Diabetes. 2017 Aug;41(4):401-406. doi: 10.1016/j.jcjd.2016.12.009. Epub 2017 Apr 27. Review.

5.

Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass?

Chondronikola M, Harris LL, Klein S.

J Intern Med. 2016 Nov;280(5):476-486. doi: 10.1111/joim.12527. Epub 2016 Oct 14. Review.

6.

Alterations in gut microbiota during remission and recurrence of diabetes after duodenal-jejunal bypass in rats.

Zhong MW, Liu SZ, Zhang GY, Zhang X, Liu T, Hu SY.

World J Gastroenterol. 2016 Aug 7;22(29):6706-15. doi: 10.3748/wjg.v22.i29.6706.

7.

Long-term Microvascular Disease Outcomes in Patients With Type 2 Diabetes After Bariatric Surgery: Evidence for the Legacy Effect of Surgery.

Coleman KJ, Haneuse S, Johnson E, Bogart A, Fisher D, O'Connor PJ, Sherwood NE, Sidney S, Theis MK, Anau J, Schroeder EB, O'Brien R, Arterburn D.

Diabetes Care. 2016 Aug;39(8):1400-7. doi: 10.2337/dc16-0194. Epub 2016 Jun 6.

8.

Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications.

Adams TD, Arterburn DE, Nathan DM, Eckel RH.

Diabetes Care. 2016 Jun;39(6):912-23. doi: 10.2337/dc16-0157. Review.

9.

APOLO-Bari, an internet-based program for longitudinal support of bariatric surgery patients: study protocol for a randomized controlled trial.

Conceição EM, Machado PP, Vaz AR, Pinto-Bastos A, Ramalho S, Silva C, Arrojado F.

Trials. 2016 Mar 1;17(1):114. doi: 10.1186/s13063-016-1246-z.

10.

Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity.

Val-Laillet D, Aarts E, Weber B, Ferrari M, Quaresima V, Stoeckel LE, Alonso-Alonso M, Audette M, Malbert CH, Stice E.

Neuroimage Clin. 2015 Mar 24;8:1-31. doi: 10.1016/j.nicl.2015.03.016. eCollection 2015. Review.

11.

Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose?

Raffaelli M, Sessa L, Mingrone G, Bellantone R.

Diabetes Metab Syndr Obes. 2015 Jun 8;8:255-62. doi: 10.2147/DMSO.S50659. eCollection 2015. Review.

12.

Bariatric surgery in morbidly obese insulin resistant humans normalises insulin signalling but not insulin-stimulated glucose disposal.

Chen MZ, Hudson CA, Vincent EE, de Berker DA, May MT, Hers I, Dayan CM, Andrews RC, Tavaré JM.

PLoS One. 2015 Apr 13;10(4):e0120084. doi: 10.1371/journal.pone.0120084. eCollection 2015.

13.

Metabolic bariatric surgery and type 2 diabetes mellitus: an endocrinologist's perspective.

Ganguly S, Tan HC, Lee PC, Tham KW.

J Biomed Res. 2015 Apr;29(2):105-11. doi: 10.7555/JBR.29.20140127. Epub 2015 Mar 3. Review.

14.

Recent advances in bariatric/metabolic surgery: appraisal of clinical evidence.

Lee WJ, Almulaifi A.

J Biomed Res. 2015 Apr;29(2):98-104. doi: 10.7555/JBR.28.20140120. Epub 2014 Dec 1. Review.

15.

Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus.

Pok EH, Lee WJ.

World J Gastroenterol. 2014 Oct 21;20(39):14315-28. doi: 10.3748/wjg.v20.i39.14315. Review.

16.

Evaluating the mechanisms of improved glucose homeostasis after bariatric surgery in Ossabaw miniature swine.

Sham JG, Simianu VV, Wright AS, Stewart SD, Alloosh M, Sturek M, Cummings DE, Flum DR.

J Diabetes Res. 2014;2014:526972. doi: 10.1155/2014/526972. Epub 2014 Aug 24.

17.

Relationship between gut hormones and glucose homeostasis after bariatric surgery.

Sala PC, Torrinhas RS, Giannella-Neto D, Waitzberg DL.

Diabetol Metab Syndr. 2014 Aug 16;6(1):87. doi: 10.1186/1758-5996-6-87. eCollection 2014. Review.

18.

Type 2 diabetes mellitus control and atherosclerosis prevention in a non-obese rat model using duodenal-jejunal bypass.

Chen X, Huang Z, Ran W, Liao G, Zha L, Wang Z.

Exp Ther Med. 2014 Sep;8(3):856-862. Epub 2014 Jul 7.

19.

Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis.

Wang GF, Yan YX, Xu N, Yin D, Hui Y, Zhang JP, Han GJ, Ma N, Wu Y, Xu JZ, Yang T.

Obes Surg. 2015 Feb;25(2):199-208. doi: 10.1007/s11695-014-1391-y.

20.

Effects of bariatric surgery on metabolic and nutritional parameters in severely obese Korean patients with type 2 diabetes: A prospective 2-year follow up.

Kim MK, Kim W, Kwon HS, Baek KH, Kim EK, Song KH.

J Diabetes Investig. 2014 Mar 23;5(2):221-7. doi: 10.1111/jdi.12137. Epub 2013 Oct 10.

Supplemental Content

Support Center